Author:
Hardt Joshua I.,Perlmutter Joel S.,Smith Christopher J.,Quick Kevin L.,Wei Ling,Chakraborty Subhasish K.,Dugan Laura L.
Funder
National Institute of Neurological Disorders and Stroke
National Institute on Aging
John A. Hartford Foundation
American Federation for Aging Research
U.S. Department of Veterans Affairs
American Parkinson Disease Association
Elliot Stein Family and Jack Buck Fund
Selma Hartke Fund for Aging Research
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. Dugan LL, Lovett E, Quick KL, Lotharius J, Lin TT, O’Malley KL. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord. 2001;7:243–6.
2. Ali SS, Hardt JI, Quick KL, Sook Kim-Han J, Erlanger BF, Huang TT, et al. A biologically effective fullerene (C(60)) derivative with superoxide dismutase mimetic properties. Free Radic Biol Med. 2004;37:1191–202.
3. Quick KL, Ali SS, Arch R, Xiong C, Wozniak D, Dugan LL. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging. 2008;29:117–28.
4. Dugan LL, Gabrielesen JK, Yu SP, Lin T-S, Choi DW. Buckminsterfullerenol free radical scavengers reduce ex-citotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis. 1996;3(129–35):305–10.
5. Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A. 1997;94:9434–9.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献